Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A study out of Johns Hopkins Medical Institutions provides new evidence that fluorodeoxyglucose (FDG) — positron emission tomography/CT (PET/CT) is not only more accurate than CT, but it also could save the U.S. health care system $150 million per year if it was used, instead of CT, to identify which patients with relapsed diffuse large B-cell lymphoma (DLBCL) stand to benefit from stem cell transplants.

PET/CT could save millions in ID of transplant cases